NEOCINE

Pharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products including personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control

Computer software for the identification and analysis of neoepitopes that control tumors in vivo; software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies

Scientific research and development in the field of oncology, specifically focused on identifying and analyzing neoepitopes that control tumors in vivo for the development of personalized cancer vaccines; medical and scientific research related to the processing of cancer and normal protein sets, identification of high-quality patient-specific neoepitopes, and design of immunotherapeutic treatments; providing temporary use of non-downloadable software for the prediction of neoepitope immunogenicity and the design of targeted cancer vaccines

Medical analysis services for the treatment of cancer, including the identification and analysis of neoepitopes that control tumors in vivo; medical services, namely, providing therapies for treating cancer; medical testing and diagnostic services for processing cancer and normal protein sets to identify high-quality patient-specific neoepitopes for personalized cancer vaccine development; preparation and dispensing of personalized immunotherapies, including neoepitope-based cancer vaccines tailored to individual patient profiles